# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000059478-24-000101
Filing Date
2024-03-22
Accepted
2024-03-22 16:26:00
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | llydefa14a2024_additionalm.htm | DEFA14A | 12864
2 |  | finalnotices-2024_pagex1.jpg | GRAPHIC | 507870
3 |  | finalnotices-2024_pagex2.jpg | GRAPHIC | 501058
4 |  | finalnotices-2024_pagex3.jpg | GRAPHIC | 505170
5 |  | finalnotices-2024_pagex4.jpg | GRAPHIC | 501062
| Complete submission text file | 0000059478-24-000101.txt |  | 2788402

Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06351 | Film No.: 24775608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)